PIK3CA hotspot mutations differentially impact responses to MET targeting in MET-driven and non-driven preclinical cancer models

Lluís Nisa(University of Bern), Michaela Medová(University of Bern)
Molecular Cancer
May 22, 2017
Cited by 25


Related Papers